Cargando…

Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors

Induced pluripotent stem (iPS) cells are at the forefront of research in regenerative medicine and are envisaged as a source for personalized tissue repair and cell replacement therapy. Here, we demonstrate for the first time that oligodendrocyte progenitors (OPs) can be derived from iPS cells gener...

Descripción completa

Detalles Bibliográficos
Autores principales: All, Angelo H., Gharibani, Payam, Gupta, Siddharth, Bazley, Faith A., Pashai, Nikta, Chou, Bin-Kuan, Shah, Sandeep, Resar, Linda M., Cheng, Linzhao, Gearhart, John D., Kerr, Candace L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311989/
https://www.ncbi.nlm.nih.gov/pubmed/25635918
http://dx.doi.org/10.1371/journal.pone.0116933
_version_ 1782355074659385344
author All, Angelo H.
Gharibani, Payam
Gupta, Siddharth
Bazley, Faith A.
Pashai, Nikta
Chou, Bin-Kuan
Shah, Sandeep
Resar, Linda M.
Cheng, Linzhao
Gearhart, John D.
Kerr, Candace L.
author_facet All, Angelo H.
Gharibani, Payam
Gupta, Siddharth
Bazley, Faith A.
Pashai, Nikta
Chou, Bin-Kuan
Shah, Sandeep
Resar, Linda M.
Cheng, Linzhao
Gearhart, John D.
Kerr, Candace L.
author_sort All, Angelo H.
collection PubMed
description Induced pluripotent stem (iPS) cells are at the forefront of research in regenerative medicine and are envisaged as a source for personalized tissue repair and cell replacement therapy. Here, we demonstrate for the first time that oligodendrocyte progenitors (OPs) can be derived from iPS cells generated using either an episomal, non-integrating plasmid approach or standard integrating retroviruses that survive and differentiate into mature oligodendrocytes after early transplantation into the injured spinal cord. The efficiency of OP differentiation in all 3 lines tested ranged from 40% to 60% of total cells, comparable to those derived from human embryonic stem cells. iPS cell lines derived using episomal vectors or retroviruses generated a similar number of early neural progenitors and glial progenitors while the episomal plasmid-derived iPS line generated more OPs expressing late markers O1 and RIP. Moreover, we discovered that iPS-derived OPs (iPS-OPs) engrafted 24 hours following a moderate contusive spinal cord injury (SCI) in rats survived for approximately two months and that more than 70% of the transplanted cells differentiated into mature oligodendrocytes that expressed myelin associated proteins. Transplanted OPs resulted in a significant increase in the number of myelinated axons in animals that received a transplantation 24 h after injury. In addition, nearly a 5-fold reduction in cavity size and reduced glial scarring was seen in iPS-treated groups compared to the control group, which was injected with heat-killed iPS-OPs. Although further investigation is needed to understand the mechanisms involved, these results provide evidence that patient-specific, iPS-derived OPs can survive for three months and improve behavioral assessment (BBB) after acute transplantation into SCI. This is significant as determining the time in which stem cells are injected after SCI may influence their survival and differentiation capacity.
format Online
Article
Text
id pubmed-4311989
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43119892015-02-13 Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors All, Angelo H. Gharibani, Payam Gupta, Siddharth Bazley, Faith A. Pashai, Nikta Chou, Bin-Kuan Shah, Sandeep Resar, Linda M. Cheng, Linzhao Gearhart, John D. Kerr, Candace L. PLoS One Research Article Induced pluripotent stem (iPS) cells are at the forefront of research in regenerative medicine and are envisaged as a source for personalized tissue repair and cell replacement therapy. Here, we demonstrate for the first time that oligodendrocyte progenitors (OPs) can be derived from iPS cells generated using either an episomal, non-integrating plasmid approach or standard integrating retroviruses that survive and differentiate into mature oligodendrocytes after early transplantation into the injured spinal cord. The efficiency of OP differentiation in all 3 lines tested ranged from 40% to 60% of total cells, comparable to those derived from human embryonic stem cells. iPS cell lines derived using episomal vectors or retroviruses generated a similar number of early neural progenitors and glial progenitors while the episomal plasmid-derived iPS line generated more OPs expressing late markers O1 and RIP. Moreover, we discovered that iPS-derived OPs (iPS-OPs) engrafted 24 hours following a moderate contusive spinal cord injury (SCI) in rats survived for approximately two months and that more than 70% of the transplanted cells differentiated into mature oligodendrocytes that expressed myelin associated proteins. Transplanted OPs resulted in a significant increase in the number of myelinated axons in animals that received a transplantation 24 h after injury. In addition, nearly a 5-fold reduction in cavity size and reduced glial scarring was seen in iPS-treated groups compared to the control group, which was injected with heat-killed iPS-OPs. Although further investigation is needed to understand the mechanisms involved, these results provide evidence that patient-specific, iPS-derived OPs can survive for three months and improve behavioral assessment (BBB) after acute transplantation into SCI. This is significant as determining the time in which stem cells are injected after SCI may influence their survival and differentiation capacity. Public Library of Science 2015-01-30 /pmc/articles/PMC4311989/ /pubmed/25635918 http://dx.doi.org/10.1371/journal.pone.0116933 Text en © 2015 All et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
All, Angelo H.
Gharibani, Payam
Gupta, Siddharth
Bazley, Faith A.
Pashai, Nikta
Chou, Bin-Kuan
Shah, Sandeep
Resar, Linda M.
Cheng, Linzhao
Gearhart, John D.
Kerr, Candace L.
Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors
title Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors
title_full Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors
title_fullStr Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors
title_full_unstemmed Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors
title_short Early Intervention for Spinal Cord Injury with Human Induced Pluripotent Stem Cells Oligodendrocyte Progenitors
title_sort early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311989/
https://www.ncbi.nlm.nih.gov/pubmed/25635918
http://dx.doi.org/10.1371/journal.pone.0116933
work_keys_str_mv AT allangeloh earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors
AT gharibanipayam earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors
AT guptasiddharth earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors
AT bazleyfaitha earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors
AT pashainikta earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors
AT choubinkuan earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors
AT shahsandeep earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors
AT resarlindam earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors
AT chenglinzhao earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors
AT gearhartjohnd earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors
AT kerrcandacel earlyinterventionforspinalcordinjurywithhumaninducedpluripotentstemcellsoligodendrocyteprogenitors